Articles tagged with Cocaine Addiction
Researchers analyzed Oregon Medicaid case data and found that severe burns requiring hospital-level care are a growing threat in the overdose epidemic. People who smoke drugs like fentanyl and methamphetamine account for most of these cases, with butane torches posing a significant risk due to locking mechanisms.
Researchers found that GLP-1 medications are effective at reducing the risk of developing substance use disorders across all major addictive substances, including a 14% reduced risk for developing any substance use disorder. The study also showed significant reductions in severe harm, including overdose and death, among patients with p...
A $2.67 million gift from the estate of Dr. William A. Gibson will establish the Michael Conner Gibson Endowed Professorship in Psychology and the Michael Conner Gibson Research Endowment, accelerating UH's addiction research program.
A new study found that nearly half of patients discharged with take-home methadone successfully connected to treatment within 72 hours. The likelihood of successful follow-up increased if patients were already enrolled in an OTP or received higher methadone doses.
A study at the University of North Carolina Chapel Hill found that brain immune cells, called microglia, drive drug craving by stripping away support structures in astrocytes. Blocking this process reduces relapse behaviors and may help reduce risk of relapse in people recovering from addiction.
A specific 'anti-reward' brain circuit becomes hyperactive during cocaine withdrawal, driving discomfort and pushing users back toward the drug. However, this circuit may also serve as a protective mechanism, potentially helping to develop new therapies targeting emotional pain of withdrawal.
Researchers identified reelin as a marker for cocaine-activated medium spiny neurons in the nucleus accumbens, which controls drug-related behavior. Knocking down reelin expression impaired excitability of these neurons and abolished cocaine-induced behavioral changes.
Researchers created genetically modified fruit flies that become addicted to cocaine, revealing a potential model for understanding and treating cocaine use disorder. The study's findings suggest that the key to preventing cocaine addiction lies in the flies' ability to detect bitter flavors, which can be mimicked in humans.
A WVU microbiology student has discovered a new species of fungus, Periglandula clandestina, that produces effects similar to the semisynthetic drug LSD. The fungus is highly efficient at making ergot alkaloids, which can be used therapeutically to treat conditions like depression and addiction.
A new study uses a fruit fly model to investigate the genetic basis of cocaine addiction. By genetically modifying bitter-sensing receptors in fruit flies, researchers found that these flies developed a preference for cocaine over sugar. This study suggests that genes involved in human cocaine addiction may also be active in fruit flies.
A novel brain study uncovers the critical role of the HDAC5 enzyme in regulating gene expression and neuronal activity, which can trigger relapse in individuals with substance use disorders. The study highlights a new molecular target for developing novel treatments to reduce relapse risk.
A study found that long-term cocaine use increases impulsivity in healthy rats, contradicting the belief that high impulsivity predicts cocaine use. This contradicts research on impulsive choice and delay-discounting tasks.
Researchers at Penn Nursing have discovered a critical brain circuit that regulates cocaine-seeking behavior, which they believe can be targeted by developing new GLP-1-based treatments. By understanding how this circuit functions, scientists may develop innovative therapies to treat cocaine use disorder.
A new study found that rats' responses to cocaine paired with aversive quinine reveal individual susceptibility to addiction. The research suggests that people's reactions to the unpleasant aspects of drug consumption can play a crucial role in determining their risk of developing substance use disorders.
Dr. Volkow emphasizes the importance of prevention strategies and research on stress, trauma, and social determinants in substance use disorders. She also highlights promising new directions in treatment, including GLP1 medications, to address the treatment gap in addiction.
Researchers at UC Irvine discovered a rosemary extract compound that can reduce cocaine sensitivity by modulating the brain's reward response. The study found that carnosic acid selectively binds to affected channels in the globus pallidus externus, providing a potential avenue for reducing response to cocaine.
Researchers at Medical University of South Carolina found that cocaine triggers a specific protein, NPAS4, which hijacks brain circuitry and promotes further drug use. Inhibiting these cells eliminates drug-seeking behavior in mice.
Researchers discovered how cocaine affects the dopamine transporter, a protein that regulates dopamine levels in the brain. This knowledge could pave the way for medical treatments for cocaine abuse and potentially other addictive substances.
Researchers have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems. A largely overlapping population of cells respond to both addictive drugs and natural rewards, leading to behavior directed toward drug-seeking and away from natural rewards.
A UNIGE team found that impulsivity, not dopamine production, predicts cocaine abuse. The study suggests alternative mechanisms controlling dopamine release may drive individual vulnerability to drugs.
A study by researchers at UNC School of Medicine found that chronic cocaine use alters the functional networks in the brain, including the default mode network and salience network. This disruption can make it harder for individuals to focus, control impulses, or feel motivated without the drug.
The University of Pittsburgh School of Pharmacy's PERU has received a $7.8 million grant to develop and implement measurement-based care into community opioid treatment programs across Pennsylvania. This project aims to improve treatment access, promote recovery, and reduce fatal overdoses by addressing patient needs through personaliz...
A recent study by researchers at the University of Texas at Arlington found that women are more susceptible to cocaine addiction than men due to fluctuations in sex hormones. The study discovered that the female sex hormone estradiol enhances the rewarding effects of cocaine, leading to increased sensitivity among females.
New research at UC disrupts conventional wisdom that people take cocaine for positive reinforcement, suggesting a pharmacological equation behind the behavior. The study suggests low doses produce reinforcing effects, while high doses have rate-limiting effects, revealing a shift in understanding of cocaine self-administration.
Researchers found that chronic cocaine users have altered neural error signals when evaluating rewards, leading to poorer decision-making and a higher risk of relapse. The study provides strong evidence for the underlying mechanisms of addiction and may lead to new treatment strategies.
Researchers created a unique, cell-by-cell atlas of the amygdala to identify potential new treatments for cocaine addiction. The study revealed connections between addiction behaviors and genes involved in energy metabolism, offering a brand-new way of thinking about the molecular biology of cocaine addiction.
US overdose deaths involving fentanyl and stimulants increased 50-fold from 2010 to 2021, with stimulants becoming most common drug class found in fentanyl-involved overdoses. The trend disproportionately affects racial/ethnic minority communities, particularly Black and African American people.
Researchers have developed a new method to adapt Ritalin to tackle cocaine abuse, overcoming a chemical hurdle that previously limited the potential of methylphenidate derivatives. This breakthrough could lead to more effective treatment options for cocaine addiction.
Researchers at Texas A&M University found that substance use impairs cognitive flexibility by inhibiting specific neurons. Chronic cocaine or alcohol use alters the local inhibitory brain circuit, leading to decreased cognitive flexibility and increased risk of academic deficits and lower quality of life.
A study by Penn State researchers found that minority communities bore the brunt of the opioid crisis, with Black men and American Indian/Native Alaskan men and women disproportionately affected. The researchers suggest that race- and gender-specific interventions may be more effective in preventing overdose deaths.
A new study analyzing death records data found that men had a 2–3 times greater rate of overdose mortality from opioids and psychostimulants. The researchers noted that biological, behavioral, and social factors likely combined to increase the mortality risk for men.
A study found that harm reduction treatment reduced substance use, including cannabis and polysubstance use, among people experiencing homelessness. Participants in the treatment group used cannabis 41% fewer days than the control group. The approach led to improved quality of life and basic needs, making it a sustainable option.
Cocaine use disorder has been rising for over a decade, with no robust treatment available. Researchers are using cocaine contingency management to provide cash or value in exchange for drug-free urine samples, aiming to change an individual's temporal horizon and reduce consumption. The study aims to guide innovative interventions tha...
Researchers found that environmental context influences drug dependence by associating psychostimulant effects with specific environments. The study observed behavioral sensitization and brain activation patterns in mice with cocaine dependence, mirroring human cravings for a specific environment or location.
A new Northwestern Medicine study found that only 7% of Medicaid enrollees with opioid use disorder (OUD) received residential treatment, highlighting a significant gap in care. Residential treatment centers provide structured support and are considered one of the best treatments for severe substance use.
Researchers have discovered that cocaine addiction is associated with faster brain aging, with changes in DNA methylation in the prefrontal cortex contributing to this effect. The study, which analyzed cryo-preserved brains of deceased male donors, found that cells in this region appeared biologically older in individuals with CUD.
Research found that cocaine use disorder causes significant gene expression changes in brain regions associated with reward and habit formation, contributing to persistent behavioral abnormalities. The study also identified overlapping molecular changes between cocaine and opioid use disorders, offering potential for targeted treatments.
A new hotline has shown promising results in preventing overdoses and saving lives by providing virtual supervision for people using substances alone. The National Overdose Response Service received over 2,100 calls from unique callers, with no reported deaths during a pilot period.
Researchers believe that changes in the brain's orexin system promote drug-seeking behavior and that existing insomnia treatments could reduce or eliminate cravings. Studies have shown that blocking this system reverses addiction in animals and reduces opioid cravings in human subjects.
Research reveals that common gut bacteria enhance cocaine effects in mice by consuming glycine, leading to behavior abnormalities. Supplementing glycine or using a genetically modified bacteria reduces response to cocaine, demonstrating its role as an addiction mediator.
A study found impairments in the prefrontal cortex-habenula circuit, critical for regulating executive functions and reward, in people with cocaine or heroin addiction. The circuit's microstructural features were analyzed using diffusion MRI tractography, revealing reduced coherence in white matter fibers.
A recent study from the University of Geneva suggests that ketamine's therapeutic use may be safe due to its limited impact on dopamine levels and neuronal communication. The research found that ketamine triggers a short increase in dopamine, but also inhibits a specific receptor that prevents addiction progression.
A new study by Northwestern University predicts a worsening wave of opioid overdoses globally, with no geographic distinction between rural and urban areas. The lethal combination of synthetic opioids and stimulants like cocaine and methamphetamines will be particularly deadly.
Researchers discovered that blocking certain acetylcholine receptors in the lateral habenula balances reward and aversion, making it harder to resist seeking cocaine. This finding identifies a new role for these receptors as a potential target for treating cocaine use disorder.
Researchers at Johns Hopkins Medicine discovered a molecular connector, BASP1, that helps cocaine latch on to brain cells, even at low doses. This finding may explain why women are more susceptible to cocaine addiction and could lead to new treatments.
A study published in Nature Communications sheds light on dopamine transporter (DAT) function, which regulates brain reward centre communication. The researchers discovered DAT depends on potassium, not just sodium, rewriting textbooks on its mechanism.
The opioid crisis in the US has reached epidemic levels, with over 100,000 drug overdose deaths reported for the first time. The US Centers for Disease Control and Prevention attributes the rise to abuse of synthetic opioid fentanyl and the COVID-19 pandemic.
Researchers found that exposure to addiction medicine consult teams led to a significantly reduced risk of death within three months of discharge. Medication played a key role in reducing mortality for patients with opioid use disorders, while other components may be crucial for those with alcohol use disorder.
Research reveals that HIV-positive individuals with cocaine addiction struggle to withhold behavioral responses due to distinct brain activity patterns. This finding highlights the need for targeted interventions to address dual diagnosis in recovery programs.
Researchers found that methamphetamine, cocaine, and nicotine withdrawal share similar features in mouse brains, including reduced modularity and increased functional connectivity. This reorganization may contribute to the addictive nature of psychostimulants.
Research in mice reveals that drug withdrawal alters brain activity patterns, causing increased functional connectivity and decreased modularity. This universal effect may be a common trait among different types of addictive drugs.
Researchers discovered serotonin helps regulate dopamine levels, reducing addiction rates to 20% in humans. The study used mice self-administering cocaine and adding unpleasant stimuli, revealing serotonin's crucial role in curbing addiction.
Researchers have created two unique collections of over 20,000 biological samples from laboratory rats to study the biological bases and consequences of cocaine and oxycodone addiction. The biobanks provide deeper insight into the paths and pathologies of these addictions.
A team of neurobiologists identified a brain region, subthalamic nucleus, that predicts addiction in rats. Abnormal activity in this region was observed in future addicted individuals before punishment exposure.
A study by Université de Montréal psychiatry professor Didier Jutras-Aswad and his team found that cannabidiol is not an effective treatment for cocaine use disorder. The 78-participant clinical trial showed no reduction in craving or relapse risk with cannabidiol, contrary to its growing popularity as a potential addiction treatment.
Research reveals two gene mutations in nicotinic receptors may confer 'protection' against cocaine addiction by modulating an early phase in the addiction cycle. The mutations reduce voluntary intake of cocaine and slow transition from first use to signs of addiction.
A new study suggests that a modified form of the opioid medication buprenorphine, known as BU10119, may help curb cocaine relapse with improved effectiveness and lower abuse potential. The research was conducted using mouse models and found modest improvements in preventing cocaine relapse while minimizing addiction risk.
Researchers at the University of California, Irvine have discovered a key receptor for dopamine called D2R that intervenes in cocaine's modifying functions in the striatum. Disrupting D2R signaling may lead to new therapeutic strategies for treating cocaine addiction.
Researchers found that smoked cannabis use impaired executive functions and increased the likelihood of relapse among cocaine addicts. The study suggests that harm reduction strategies using cannabis may not be effective in treating cocaine addiction.
Researchers at the University of Malaga found that social interaction can diminish interest in cocaine. The study used an animal model and showed that positive stimuli like social interaction with another animal reduced preference for the drug.